-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Supernus Pharmaceuticals, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2010 to 2022.
- Supernus Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was $38.5M.
- Supernus Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was $60.7M, a 13.6% increase from 2021.
- Supernus Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was $53.4M, a 57.9% decline from 2020.
- Supernus Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2020 was $127M, a 12.3% increase from 2019.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)